Heart Failure Drugs (details) Flashcards

1
Q

What is the MOA of sacubitril?

A

It inhibits neprilysin (breaks down BNP) –> prolongs BNP effects (ie: vasodilation, natriuresis and diuresis) –> beneficial for heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why does sacubitril need to be combined with valsartan?

A

Because neprilysin also breaks down ANGII, so when sacubitril inhibits neprilysin, more ANGII would be broken down too –> bad for heart failure because more sodium and water retention occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the MOA of valsartan?

A

Valsartan is a angiotensin ii receptor blocker, thus, when combined with sacubitril, it helps to mitigate the negative effects of ANGII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the pharmacological features of sacubitril-valsartan?

A
  • Can be used to replace ARB/ACE inhibitors and therefore can be combined with other drugs normally combined with ARB or ACE inhibitors

Because neprilysin also breaks down bradykinin, so sacubitril-valsartan will inhibit neprilysin and the break down of bradykinin will be inhibited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the adverse effects of sacubitril-valsartan?

A

1) Hypotension
2) Hyperkalemia
3) Renal failure (rare)
4) Cough (because bradykinin is not broken down)
5) Angioedema (because bradykinin is not broken down)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which part of the loop of Henle does loop diuretics work on?

A

The thick ascending limb of the loop of Henle.

This is where NaCl is actively reabsorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the MOA of loop diuretics?

A

1) Selective inhibition of the luminal Na+/K+/2Cl- transporter in the thick ascending limb of the loop of Henle, and increases Mg+ and Ca2+ excretion
2) Furosemide increases renal blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What drug class should be taken together with loop diuretics and why?

A

NSAIDs

Loop diuretics induce renal PG synthesis, so NSAIDs should be taken to offset this effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the PK properties of loop diuretics?

A

1) They are rapidly absorbed, and thus have short onset of action.
2) The duration of effect for furosemide is usually 2-3 hours.
3) They are eliminated by tubular secretion as well as by glomerular filtration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the clinical uses of loop diuretics?

A

1) Acute pulmonary edema and other edema (can be used for acute PE because of its rapid onset of action)
2) Acute hyperkalemia
3) Acute renal failure
4) Anion overdose - toxic ingestions of bromide, fluoride and iodide (since loop diuretics inhibit the luminal Na+/K+/2Cl- transporter and Cl- is affected, the other halogen ions would be affected as well since they all belong to the same valence group)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the adverse effects of loop diuretics?

A

1) hypokalemic metabolic alkalosis
2) ototoxicity
3) hyperuricemia
4) hypomagnesemia
5) hypocalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What class of drugs should you avoid taking together with loop diuretics?

A

Aminoglycosides

because both aminoglycosides and loop diuretics cause ototoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which part of the nephron will potassium-sparing diuretics exert their influence on?

A

The collecting tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the MOA of potassium-sparing diuretics?

A

They block either the aldosterone receptor or the sodium channel.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which of the potassium-sparing diuretics block the aldosterone receptor?

A

Spironolactone and eplerenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which of the potassium-sparing diuretics block the sodium channel?

A

Triamterene and amiloride

16
Q

If you want to use 2 diuretics, what can you use?

A

1 potassium-sparing diuretic + 1 loop diuretic OR 1 thiazide

no point using spironolactone together with triamterene even though they block different receptors because they’re still in the same pathway.

Pharmaco principle: if you want to use combo therapy, NEVER use 2 drugs that work on the same pathway!

17
Q

What is the effect of potassium-sparing diuretics on potassium?

A

Potassium secretion will be decreased since sodium reabsorption is decreased

18
Q

Discuss the PK properties of spironolactone, triamterene and amiloride

A

Spironolactone: slow onset of action, requires several days before full therapeutic effect is achieved

Triamterene: metabolised in the liver, shorter half-life and must be given more frequently than amiloride

Amiloride: excreted unchanged in the urine

19
Q

What are the clinical uses of potassium-sparing diuretics?

A

1) Diuretic
2) Hyperaldosteronism (ie: over-retention of sodium)

20
Q

What are the adverse effects of potassium-sparing diuretics?

A

1) Hyperkalemia
2) Metabolic acidosis
3) Gynecomastia (only for spironolactone)
4) Acute renal failure (when triamterene is taken together with indomethacin)
5) Kidney stones (with triamterene)

21
Q

What are the MOAs of hydralazine?

A

Direct arteriole vasodilator –> reduces peripheral resistance –> compensatory release of epinephrine/ norepinephrine –> increase venous return and cardiac output + reduces afterload (directly via arteriole vasodilation + indirectly through release of epinephrine and norepinephrine)

22
Q

What are the clinical indications of hydralazine?

A

1) HFrEF (given PO in combination with ISDN)
2) Essential hypertension (ie: primary hypertension). Given PO
3) Acute onset, severe peripartum or post-partum hypertension (>15min). Given IV

23
Q

What are the adverse effects of hydralazine?

A

1) Symptoms associated with baroreflex associated sympathetic activation (ie: flushing, hypotension, tachycardia)

2) Hydralazine-induced lupus syndrome (HILS): athralgia, myalgia, serositis, fever
- Dose dependent & higher chance with long-term use
- Can be resolved with hydralazine discontinuation

3) Contraindicated in coronary artery disease
- Hydralazine stimulates the sympathetic nervous system –> increased cardiac output/ oxygen demand –> myocardial ischemia

24
(popular exam question!) Compare the PK properties of digoxin and digitoxin
SIMILARITIES - both administered PO - both have large volume of distribution DIFFERENCES - digitoxin is extensively metabolised by the liver, digoxin is not extensively metabolised (almost 2/3 is excreted unchanged) - digitoxin is excreted in the feces, digoxin is excreted by the kidney - digoxin has a faster onset of action than digitoxin - digoxin has a shorter half life than digitoxin - digoxin binds to proteins less than digitoxin
25
What is the MOA of the cardiac glycosides?
Inhibition of sodium potassium ATPase --> increase in intracellular [Na+] --> impairs functioning of sodium-calcium exchanger --> decrease in calcium efflux --> CICR induced --> cardiac myocytes activated --> stronger systolic contraction
26
What are the clinical uses of cardiac glycosides?
1) systolic dysfunction 2) atrial fibrillation
27
What are the adverse effects of cardiac glycosides?
1) Progressively more severe dysrhythmia: AV block, AF, VF 2) GI effects: anorexia, nausea, and vomiting 3) CNS effects: headache, fatigue, confusion, blurred vision